{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:04:06Z","timestamp":1778493846103,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T00:00:00Z","timestamp":1503532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"U.S. Food and Drug Administration (US)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s40264-017-0591-5","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T11:24:06Z","timestamp":1503573846000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Enrollment and Retention in 34 United States Pregnancy Registries Contrasted with the Manufacturer\u2019s Capture of Spontaneous Reports for Exposed Pregnancies"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7976-3462","authenticated-orcid":false,"given":"Steven T.","family":"Bird","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Gelperin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lockwood","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Mohamoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sengwee","family":"Toh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hampp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,24]]},"reference":[{"key":"591_CR1","unstructured":"US Food and Drug Administration. Guidance for Industry. Establishing Pregnancy Exposure Registries. Aug 2002. Available at: \n                        https:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm071639.pdf\n                        \n                    . Accessed 10 June 2016."},{"key":"591_CR2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejogrb.2015.11.015","volume":"197","author":"V Vannappagari","year":"2016","unstructured":"Vannappagari V, Albano JD, Koram N, Tilson H, Scheuerle AE, Napier MD. Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry. Eur J Obstet Gynecol Reprod Biol. 2016;197:6\u201310.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"21","key":"591_CR3","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","volume":"78","author":"S Hern\u00e1ndez-D\u00edaz","year":"2012","unstructured":"Hern\u00e1ndez-D\u00edaz S, Smith CR, Shen A, Mittendorf R, Hauser WA, Yerby M, Holmes LB. North American AED Pregnancy Registry. Comparative safety of antiepileptic drugs during pregnancy. Neurology. 2012;78(21):1692\u20139.","journal-title":"Neurology"},{"key":"591_CR4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-012-2368-y","volume":"137","author":"F Zagouri","year":"2013","unstructured":"Zagouri F, Sergentanis TN, Chrysikos D, Papadimitriou CA, Dimopoulos MA, Bartsch R. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137:349\u201357.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"591_CR5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0190-9622(92)70088-W","volume":"26","author":"WS Dai","year":"1992","unstructured":"Dai WS, LaBraico JM, Stern RS. Epidemiology of isotretinoin exposure during pregnancy. J Am Acad Dermatol. 1992;26(4):599\u2013606.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"591_CR6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/pds.4150","volume":"26","author":"K Gelperin","year":"2017","unstructured":"Gelperin K, Hammad H, Leishear K, Bird ST, Taylor L, Hampp C, Sahin L. A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selection. Pharmacoepidemiol Drug Saf. 2017;26(2):208\u201314.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"591_CR7","unstructured":"US Food and Drug Administration. Office of Women\u2019s Health. List of pregnancy registries. Available at: \n                        https:\/\/www.fda.gov\/ScienceResearch\/SpecialTopics\/WomensHealthResearch\/ucm251314.htm\n                        \n                    . Accessed 10 June 2016."},{"issue":"6","key":"591_CR8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJMp1014427","volume":"364","author":"RE Behrman","year":"2011","unstructured":"Behrman RE, Benner JS, Brown JS, McClellan M, Woodcock J, Platt R. Developing the sentinel system: a national resource for evidence development. N Engl J Med. 2011;364(6):498\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"591_CR9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/pds.3407","volume":"22","author":"Q Li","year":"2013","unstructured":"Li Q, Andrade SE, Cooper WO, et al. Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf. 2013;22(5):524\u201332.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"591_CR10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/pds.1100","volume":"14","author":"MA Raebel","year":"2005","unstructured":"Raebel MA, Ellis JL, Andrade SE. Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data. Pharmacoepidemiol Drug Saf. 2005;14(12):829\u201336.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"591_CR11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10995-015-1878-8","volume":"20","author":"SE Andrade","year":"2016","unstructured":"Andrade SE, Toh S, Houstoun M, et al. Surveillance of medication use during pregnancy in the mini-sentinel program. Matern Child Health J. 2016;20(4):895\u2013903.","journal-title":"Matern Child Health J"},{"key":"591_CR12","unstructured":"IMS Institute for Healthcare Informatics. NSRD Data Brief: National Sales Perspectives\u2122. Available at: \n                        https:\/\/www.imshealth.com\/files\/web\/IMSH%20Institute\/NSP_Data_Brief-.pdf\n                        \n                    . Accessed 31 June 2016."},{"issue":"Suppl 1","key":"591_CR13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/pds.2319","volume":"21","author":"D McGraw","year":"2012","unstructured":"McGraw D, Rosati K, Evans B. A policy framework for public health uses of electronic health data. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):18\u201322.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"591_CR14","unstructured":"GlaxoSmithKline. The Bupropion Pregnancy Registry Final Report. Issued Aug 2008. Available at: \n                        http:\/\/pregnancyregistry.gsk.com\/documents\/bup_report_final_2008.pdf\n                        \n                    . Accessed 20 July 2017."},{"issue":"21","key":"591_CR15","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1212\/WNL.0b013e31821ccd18","volume":"76","author":"MC Cunnington","year":"2011","unstructured":"Cunnington MC, Weil JG, Messenheimer JA, Ferber S, Yerby M, Tennis P. Final results from 18\u00a0years of the International Lamotrigine Pregnancy Registry. Neurology. 2011;76(21):1817\u201323.","journal-title":"Neurology."},{"key":"591_CR16","unstructured":"Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 January 2017. Wilmington: Registry Coordinating Center; 2017. Available at: \n                        http:\/\/www.APRegistry.com\n                        \n                    . Accessed 20 July 2017."},{"key":"591_CR17","unstructured":"US Food and Drug Administration. 2014 meeting materials; Study approaches and methods to evaluate the safety of drugs and biological products during pregnancy in the post-approval setting; public meeting, request for comments. 2014. Available at: \n                        https:\/\/www.fda.gov\/Drugs\/NewsEvents\/ucm386560.htm\n                        \n                    . Accessed 20 July 2017."},{"key":"591_CR18","unstructured":"Chavez N. The key role of social media in registry recruitment [abstract no. S5]. In: Presented at the 57th Annual Meeting of the Teratology Society: Denver; 24\u201328 June 2017."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-017-0591-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T10:57:21Z","timestamp":1515581841000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-017-0591-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,24]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1007\/s40264-017-0591-5","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,24]]}}}